296 related articles for article (PubMed ID: 33063421)
1. The airway microbiome in COPD, bronchiectasis and bronchiectasis-COPD overlap.
Tiew PY; Jaggi TK; Chan LLY; Chotirmall SH
Clin Respir J; 2021 Feb; 15(2):123-133. PubMed ID: 33063421
[TBL] [Abstract][Full Text] [Related]
2. High Frequency of Allergic Bronchopulmonary Aspergillosis in Bronchiectasis-COPD Overlap.
Tiew PY; Lim AYH; Keir HR; Dicker AJ; Mac Aogáin M; Pang SL; Low TB; Hassan TM; Poh ME; Xu H; Ong TH; Koh MS; Abisheganaden JA; Tee A; Chew FT; Chalmers JD; Chotirmall SH
Chest; 2022 Jan; 161(1):40-53. PubMed ID: 34364870
[TBL] [Abstract][Full Text] [Related]
3. Increased Chitotriosidase Is Associated With Aspergillus and Frequent Exacerbations in South-East Asian Patients With Bronchiectasis.
Poh TY; Tiew PY; Lim AYH; Thng KX; Binte Mohamed Ali NA; Narayana JK; Mac Aogáin M; Tien Z; Chew WM; Wai Chan AK; Keir HR; Dicker AJ; Hassan TM; Xu H; Tee AKH; Ong TH; Koh MS; Abisheganaden JA; Chalmers JD; Chotirmall SH
Chest; 2020 Aug; 158(2):512-522. PubMed ID: 32184111
[TBL] [Abstract][Full Text] [Related]
4. Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease.
Mac Aogáin M; Lau KJX; Cai Z; Kumar Narayana J; Purbojati RW; Drautz-Moses DI; Gaultier NE; Jaggi TK; Tiew PY; Ong TH; Siyue Koh M; Lim Yick Hou A; Abisheganaden JA; Tsaneva-Atanasova K; Schuster SC; Chotirmall SH
Am J Respir Crit Care Med; 2020 Aug; 202(3):433-447. PubMed ID: 32320621
[No Abstract] [Full Text] [Related]
5. Targeting respiratory microbiomes in COPD and bronchiectasis.
Mac Aogáin M; Tiew PY; Jaggi TK; Narayana JK; Singh S; Hansbro PM; Segal LN; Chotirmall SH
Expert Rev Respir Med; 2024; 18(3-4):111-125. PubMed ID: 38743428
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of sputum microbiome studies identifies airway disease-specific taxonomic and functional signatures.
Ghosh A; Saha S
J Med Microbiol; 2022 Dec; 72(12):. PubMed ID: 36748565
[No Abstract] [Full Text] [Related]
7. The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease.
Tiew PY; Mac Aogáin M; Chotirmall SH
Curr Opin Pulm Med; 2022 Mar; 28(2):121-133. PubMed ID: 34839338
[TBL] [Abstract][Full Text] [Related]
8. The alterations of oral, airway and intestine microbiota in chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Kou Z; Liu K; Qiao Z; Wang Y; Li Y; Li Y; Yu X; Han W
Front Immunol; 2024; 15():1407439. PubMed ID: 38779669
[TBL] [Abstract][Full Text] [Related]
9. Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the "Chronic Obstructive Pulmonary Disease-Bronchiectasis Association".
Huang JT; Cant E; Keir HR; Barton AK; Kuzmanova E; Shuttleworth M; Pollock J; Finch S; Polverino E; Bottier M; Dicker AJ; Shoemark A; Chalmers JD
Am J Respir Crit Care Med; 2022 Aug; 206(4):417-426. PubMed ID: 35436182
[No Abstract] [Full Text] [Related]
10. Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of Bronchiectasis.
Nigro E; Mosella M; Daniele A; Mallardo M; Accardo M; Bianco A; Perrotta F; Scialò F
Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836801
[TBL] [Abstract][Full Text] [Related]
11. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.
Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD
Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805
[TBL] [Abstract][Full Text] [Related]
12. Airway "Resistotypes" and Clinical Outcomes in Bronchiectasis.
Mac Aogáin M; Xaverius Ivan F; Jaggi TK; Richardson H; Shoemark A; Narayana JK; Dicker AJ; Koh MS; Lee KCH; Thun How O; Poh ME; Chin KK; Hou ALY; Ser Hon P; Low TB; Abisheganaden JA; Dimakou K; Digalaki A; Kosti C; Gkousiou A; Hansbro PM; Blasi F; Aliberti S; Chalmers JD; Chotirmall SH
Am J Respir Crit Care Med; 2024 Jul; 210(1):47-62. PubMed ID: 38271608
[No Abstract] [Full Text] [Related]
13. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
[TBL] [Abstract][Full Text] [Related]
14. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
[TBL] [Abstract][Full Text] [Related]
16. Mucolytic Agents and Statins Use is Associated with a Lower Risk of Acute Exacerbations in Patients with Bronchiectasis-Chronic Obstructive Pulmonary Disease Overlap.
Su VY; Perng DW; Chou TC; Chou YC; Chang YL; Hsu CC; Chou CL; Lee HC; Chen TJ; Hu PW
J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30518165
[TBL] [Abstract][Full Text] [Related]
17. Respiratory Mycoses in COPD and Bronchiectasis.
Tiew PY; Mac Aogáin M; Ter SK; Aliberti S; Chalmers JD; Chotirmall SH
Mycopathologia; 2021 Oct; 186(5):623-638. PubMed ID: 33709335
[TBL] [Abstract][Full Text] [Related]
18. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.
Ghebre MA; Pang PH; Diver S; Desai D; Bafadhel M; Haldar K; Kebadze T; Cohen S; Newbold P; Rapley L; Woods J; Rugman P; Pavord ID; Johnston SL; Barer M; May RD; Brightling CE
J Allergy Clin Immunol; 2018 Jun; 141(6):2027-2036.e12. PubMed ID: 29709671
[TBL] [Abstract][Full Text] [Related]
19. The lung microbiome and exacerbations of COPD.
Dy R; Sethi S
Curr Opin Pulm Med; 2016 May; 22(3):196-202. PubMed ID: 26964078
[TBL] [Abstract][Full Text] [Related]
20. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
